These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

852 related articles for article (PubMed ID: 36177006)

  • 1. M2-like tumor-associated macrophage-related biomarkers to construct a novel prognostic signature, reveal the immune landscape, and screen drugs in hepatocellular carcinoma.
    Qu X; Zhao X; Lin K; Wang N; Li X; Li S; Zhang L; Shi Y
    Front Immunol; 2022; 13():994019. PubMed ID: 36177006
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Integrated analysis of tumor-associated macrophages and M2 macrophages in CRC: unraveling molecular heterogeneity and developing a novel risk signature.
    Shi L; Mao H; Ma J
    BMC Med Genomics; 2024 May; 17(1):145. PubMed ID: 38802881
    [TBL] [Abstract][Full Text] [Related]  

  • 3. m
    Qu X; Zhang L; Li S; Li T; Zhao X; Wang N; Shi Y
    Oxid Med Cell Longev; 2022; 2022():8301888. PubMed ID: 36246403
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exploring the immune landscape and drug prediction of an M2 tumor-associated macrophage-related gene signature in EGFR-negative lung adenocarcinoma.
    Huang Y; Zhang Y; Duan X; Hou R; Wang Q; Shi J
    Thorac Cancer; 2024 Jun; ():. PubMed ID: 38886907
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multi-omics analysis of macrophage-associated receptor and ligand reveals a strong prognostic signature and subtypes in hepatocellular carcinoma.
    Zhao Y; Chen C; Chen K; Sun Y; He N; Zhang X; Xu J; Shen A; Zhao S
    Sci Rep; 2024 May; 14(1):12163. PubMed ID: 38806553
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of cancer-related fibroblasts (CAF) in hepatocellular carcinoma and construction of CAF-based risk signature based on single-cell RNA-seq and bulk RNA-seq data.
    Yu L; Shen N; Shi Y; Shi X; Fu X; Li S; Zhu B; Yu W; Zhang Y
    Front Immunol; 2022; 13():1009789. PubMed ID: 36211448
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development and validation of a disulfidptosis and M2 TAM-related classifier for bladder cancer to explore tumor subtypes, immune landscape and drug treatment.
    Ren C; Wang Q; Xu Z; Pan Y; Li Y; Liu X
    J Cancer Res Clin Oncol; 2023 Nov; 149(17):15805-15818. PubMed ID: 37668798
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An Unfolded Protein Response-Related mRNA Signature Predicting the Survival and Therapeutic Effect of Hepatocellular Carcinoma.
    Su Z; Wang L; Chen X; Zhong X; Wang D; Wang J; Shao L; Chen G; Wu J
    Comb Chem High Throughput Screen; 2022; 25(12):2046-2058. PubMed ID: 35125080
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comprehensive analysis of scRNA-Seq and bulk RNA-Seq reveals dynamic changes in the tumor immune microenvironment of bladder cancer and establishes a prognostic model.
    Tan Z; Chen X; Zuo J; Fu S; Wang H; Wang J
    J Transl Med; 2023 Mar; 21(1):223. PubMed ID: 36973787
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development and validation of a novel immune-related prognostic model in hepatocellular carcinoma.
    Wang Z; Zhu J; Liu Y; Liu C; Wang W; Chen F; Ma L
    J Transl Med; 2020 Feb; 18(1):67. PubMed ID: 32046766
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Integrative multi-omics analyses unravel the immunological implication and prognostic significance of CXCL12 in breast cancer.
    Gao ZJ; Fang Z; Yuan JP; Sun SR; Li B
    Front Immunol; 2023; 14():1188351. PubMed ID: 37564657
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comprehensive analysis and immune landscape of chemokines- and chemokine receptors-based signature in hepatocellular carcinoma.
    Zhang Z; Mao M; Wang F; Zhang Y; Shi J; Chang L; Wu X; Zhang Z; Xu P; Lu S
    Front Immunol; 2023; 14():1164669. PubMed ID: 37545521
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Eight-gene metabolic signature related with tumor-associated macrophages predicting overall survival for hepatocellular carcinoma.
    Huo J; Wu L; Zang Y; Dong H; Liu X; He F; Zhang X
    BMC Cancer; 2021 Jan; 21(1):31. PubMed ID: 33413205
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comprehensive Molecular Analyses of a Macrophage-Related Gene Signature With Regard to Prognosis, Immune Features, and Biomarkers for Immunotherapy in Hepatocellular Carcinoma Based on WGCNA and the LASSO Algorithm.
    Wang T; Dai L; Shen S; Yang Y; Yang M; Yang X; Qiu Y; Wang W
    Front Immunol; 2022; 13():843408. PubMed ID: 35693827
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cuproptosis-Related Signature Predicts the Prognosis, Tumor Microenvironment, and Drug Sensitivity of Hepatocellular Carcinoma.
    Qi X; Guo J; Chen G; Fang C; Hu L; Li J; Zhang C
    J Immunol Res; 2022; 2022():3393027. PubMed ID: 36438201
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Construction and validation of a novel prognostic model of neutrophil‑related genes signature of lung adenocarcinoma.
    Zhu Q; Chai Y; Jin L; Ma Y; Lu H; Chen Y; Feng W
    Sci Rep; 2023 Oct; 13(1):18226. PubMed ID: 37880277
    [TBL] [Abstract][Full Text] [Related]  

  • 17. T-cell exhaustion signatures characterize the immune landscape and predict HCC prognosis
    Chi H; Zhao S; Yang J; Gao X; Peng G; Zhang J; Xie X; Song G; Xu K; Xia Z; Chen S; Zhao J
    Front Immunol; 2023; 14():1137025. PubMed ID: 37006257
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of a novel signature based on macrophage-related marker genes to predict prognosis and immunotherapeutic effects in hepatocellular carcinoma.
    Su Y; Xue C; Gu X; Wang W; Sun Y; Zhang R; Li L
    Front Oncol; 2023; 13():1176572. PubMed ID: 37305578
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel stemness-hypoxia-related signature for prognostic stratification and immunotherapy response in hepatocellular carcinoma.
    Zhang G; Zhang K; Zhao Y; Yang Q; Lv X
    BMC Cancer; 2022 Oct; 22(1):1103. PubMed ID: 36307751
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Novel Ferroptosis-Related Long Non-Coding RNA Prognostic Signature Correlates With Genomic Heterogeneity, Immunosuppressive Phenotype, and Drug Sensitivity in Hepatocellular Carcinoma.
    Li G; Liu Y; Zhang Y; Xu Y; Zhang J; Wei X; Zhang Z; Zhang C; Feng J; Li Q; Wang G
    Front Immunol; 2022; 13():929089. PubMed ID: 35874689
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 43.